Andrea Lauterio
Overview
Explore the profile of Andrea Lauterio including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
112
Citations
958
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Liver transplantation for HBV-related liver disease: Impact of prophylaxis for HBV on HCC recurrence
Burra P, Battistella S, Turco L, Morelli M, Frassanito G, De Maria N, et al.
JHEP Rep
. 2025 Mar;
7(3):101278.
PMID: 40041120
Background & Aims: Conflicting data exist regarding optimal prophylaxis for HBV recurrence (HBV-R) after liver transplantation (LT), particularly in patients with hepatocellular carcinoma (HCC). We assessed current practices for HBV-R...
2.
Manzia T, Antonelli B, Carraro A, Conte G, Guglielmo N, Lauterio A, et al.
Hepatol Int
. 2025 Feb;
PMID: 39960604
No abstract available.
3.
Cassese G, C Giglio M, Vitale A, Lauterio A, Serenari M, Cipriani F, et al.
HPB (Oxford)
. 2025 Feb;
PMID: 39956728
Background: Recent papers report significant survival gain after liver resection in BCLC-B and -C HCC patients. The results of minimally invasive liver surgery (MILS) in such patients have not been...
4.
Gringeri E, Furlanetto A, Polacco M, Perin L, Nieddu E, Rosso E, et al.
Liver Transpl
. 2025 Jan;
PMID: 39835850
Total hepatectomy and liver transplantation have emerged as a game-changing strategy in the treatment of several liver-confined primary or metastatic tumors, opening a new era of transplant oncology. However, the...
5.
Famularo S, Milana F, Ardito F, Cipriani F, Vitale A, Lauterio A, et al.
HPB (Oxford)
. 2025 Jan;
PMID: 39800599
Background: Minimal access liver surgery (MALS) is considered superior to open liver resection (OLR) in reducing the perioperative risk in patients affected by hepatocellular carcinoma (HCC). No national-level comparisons exist...
6.
Lauterio A, Cillo U, De Carlis R, Bernasconi D, Gringeri E, Pinelli D, et al.
Ann Surg Open
. 2024 Dec;
5(4):e526.
PMID: 39711663
No abstract available.
7.
De Carlis R, Lauterio A, Schlegel A, Gringeri E, Patrono D, Camagni S, et al.
Liver Transpl
. 2024 Sep;
31(1):70-84.
PMID: 39287560
Dual hypothermic oxygenated perfusion (DHOPE) is increasingly being used to extend liver preservation to improve transplant logistics. However, little is known about its benefits in high-risk liver grafts. This study...
8.
Tarello D, Gioga F, Lauterio A, Becchetti C, Perricone G, Santi G, et al.
Monaldi Arch Chest Dis
. 2024 Sep;
PMID: 39259230
Acute-on-chronic liver failure (ACLF) is a severe clinical condition for which liver transplantation (LT) is the only curative option. Due to the recipients' generally poor pre-operative clinical conditions and extensive...
9.
Gringeri E, Furlanetto A, Billato I, Cescon M, De Carlis L, Mazzaferro V, et al.
Updates Surg
. 2024 Aug;
76(7):2505-2513.
PMID: 39210194
Liver transplantation (LT) was considered an ineffective treatment for perihilar cholangiocarcinoma (pCCA) until the successful experience of the Mayo Clinic, proposing a protocol with strict inclusion criteria and neoadjuvant radio-chemotherapy....
10.
Manzia T, Antonelli B, Carraro A, Conte G, Guglielmo N, Lauterio A, et al.
Hepatol Int
. 2024 Jul;
18(5):1416-1430.
PMID: 39009897
Purpose: Advances in surgical procedures and immunosuppressive therapies have considerably improved the outcomes of patients who have undergone liver transplantation in the past few decades. In 2020, the Italian Liver...